Zobrazeno 1 - 10
of 1 097
pro vyhledávání: '"Giuseppe BIONDI ZOCCAI"'
Autor:
Tomer Maller, Sharon Bruoha, Ranel Loutati, Shemy Carasso, Louay Taha, Pierre Sabouret, Mattia Galli, Giuseppe Biondi Zoccai, Luigi Spadafora, Danny Dvir, Mony Shuvy, Rami Jubeh, David Marmor, Nimrod Perel, Nir Levi, Itshak Amsalem, Rafael Hitter, Maayan Shrem, Michael Glikson, Elad Asher, For the Jerusalem Platelets Thrombosis, Intervention in Cardiology (JUPITER-17) Study Group
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Platelets play a key role in the natural history of aortic stenosis (AS) and after transcatheter aortic valve implantation (TAVI). An echo-based staging system stratifies patients with severe AS into 5 groups according to the asso
Externí odkaz:
https://doaj.org/article/3d0249d8efd04e37aa1b4ee3b8873771
Autor:
Ovidio De Filippo, Fabrizio D’Ascenzo, Mario Iannaccone, Maurizio Bertaina, Attilio Leone, Irene Borzillo, Emanuele Ravetti, Andrea Solano, Ilaria Pagliassotto, Marco Nebiolo, Francesco Bruno, Federico Giacobbe, Saverio Muscoli, Silvia Monticone, Maria Felice Brizzi, Giuseppe Biondi Zoccai, Gaetano Maria De Ferrari
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-15 (2023)
Abstract Background and aims Bempedoic Acid (BA) is a novel Lipid-Lowering Therapy (LLT). We performed a systematic review and meta-analysis to assess the efficacy and safety of BA in patients with hypercholesterolemia. Methods PubMed, Scopus, and Co
Externí odkaz:
https://doaj.org/article/5c80d03105884d4aaa533a6bea0df115
Autor:
Martino Pepe, Eugenio Carulli, Claudio Larosa, Gianluigi Napoli, Palma Luisa Nestola, Maria Cristina Carella, Salvatore Giordano, Rocco Tritto, Francesco Bartolomucci, Plinio Cirillo, Giuseppe Biondi Zoccai, Arturo Giordano, Marco Matteo Ciccone
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Cangrelor, the first intravenous P2Y12 inhibitor (P2Y12-I), has been approved on the basis of three large RCTs from the CHAMPION program which nevertheless have been criticized for the low bleeding risk of the enrolled patients, the large qu
Externí odkaz:
https://doaj.org/article/b36a4182a2294ddbbb20347156a09e11
Publikováno v:
Heart Vessels and Transplantation, Vol 8, Iss 1 (2024)
In the recently published clinical practice guidelines by the American Heart Association/American College of Cardiology, a central part has been dedicated to the revascularization, as new evidence came up increasing our knowledge on this relevant top
Externí odkaz:
https://doaj.org/article/f6230deef09e4c3689cc221deecb2b06
Autor:
Luca Testa, Matteo Casenghi, Enrico Criscione, Nicolas M. Van Mieghem, Didier Tchétché, Anita W. Asgar, Ole De Backer, Azeem Latib, Bernhard Reimers, Giulio Stefanini, Carlo Trani, Francesco Giannini, Antonio Bartorelli, Wojtek Wojakowski, Maciej Dabrowski, Dariusz Jagielak, Adrian P. Banning, Rajesh Kharbanda, Raul Moreno, Joachim Schofer, Christina Brinkmann, Niels van Royen, Duane Pinto, Antoni Serra, Amit Segev, Arturo Giordano, Nedy Brambilla, Mauro Agnifili, Antonio Popolo Rubbio, Mattia Squillace, Jacopo Oreglia, Rudolph Tanja, James M. McCabe, Alexander Abizaid, Michiel Voskuil, Rui Teles, Giuseppe Biondi Zoccai, Lars Sondergaard, Francesco Bedogni
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundA severe prosthesis-patient mismatch (PPM) is associated with adverse outcomes following transcatheter aortic valve replacement (TAVR) for de novo aortic stenosis or a failed surgical bioprosthesis. The impact of severe PPM in patients unde
Externí odkaz:
https://doaj.org/article/6879a92298364ddeb29b433b17d6c76a
Autor:
Adelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, Valentina Iervolino, Giuseppe Biondi Zoccai, Felicita Andreotti
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 87 (2022)
Cardiotoxic therapies, whether chemotherapeutic or antibiotic, represent a burden for patients who may need to interrupt life-saving treatment because of serious complications. Cardiotoxicity is a broad term, spanning from forms of heart failure indu
Externí odkaz:
https://doaj.org/article/4aa3eece8aa24ee0be74ed28034f8a7d
Autor:
Maurizio Forte, Michele Madonna, Sonia Schiavon, Valentina Valenti, Francesco Versaci, Giuseppe Biondi Zoccai, Giacomo Frati, Sebastiano Sciarretta
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 16, p 3874 (2019)
Atrial natriuretic peptide (ANP) is a cardiac hormone belonging to the family of natriuretic peptides (NPs). ANP exerts diuretic, natriuretic, and vasodilatory effects that contribute to maintain water−salt balance and regulate blood pressure. Besi
Externí odkaz:
https://doaj.org/article/08abfa691c074b77a40fa1c3f9c35414
Autor:
Camilla Siciliano, Isotta Chimenti, Mohsen Ibrahim, Chiara Napoletano, Giorgio Mangino, Gaia Scaletta, Giuseppe Biondi Zoccai, Erino Angelo Rendina, Antonella Calogero, Giacomo Frati, Elena De Falco Ph.D.
Publikováno v:
Cell Transplantation, Vol 24 (2015)
Nowadays, cardiac regenerative medicine is facing many limitations because of the complexity to find the most suitable stem cell source and to understand the regenerative mechanisms involved. Mesenchymal stem cells (MSCs) have shown great regenerativ
Externí odkaz:
https://doaj.org/article/8f04ac5b57d048c3a88764a0bbc373a2
Autor:
Tanya Mohammadi, Fabrizio D'Ascenzo, Martino Pepe, Stefano Bonsignore Zanghì, Marco Bernardi, Luigi Spadafora, Giacomo Frati, Mariangela Peruzzi, Gaetano Maria De Ferrari, Giuseppe Biondi-Zoccai
Publikováno v:
The American Journal of Cardiology. 193:44-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::361df1969d9754dd613547111f956331
https://doi.org/10.1016/j.amjcard.2023.01.048
https://doi.org/10.1016/j.amjcard.2023.01.048
Autor:
Pierre Sabouret, Luigi Spadafora, David Fischman, Waqas Ullah, Michel Zeitouni, Martha Gulati, Salvatore De Rosa, Michael P. Savage, Juan Pablo Costabel, Maciej Banach, Giuseppe Biondi-Zoccai, Mattia Galli
Publikováno v:
European Journal of Internal Medicine. 110:1-9
Dual antiplatelet therapy (DAPT) is the gold standard after acute coronary syndromes (ACS) or chronic coronary syndromes (CCS) undergoing percutaneous coronary intervention (PCI). Because local and systemic ischemic complications can occur particular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90fd766db204724a6d2e0dfed85167bd
https://doi.org/10.1016/j.ejim.2022.12.008
https://doi.org/10.1016/j.ejim.2022.12.008